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HIV-1 Protease inhibitors
The human immunodeficiency virus (HIV) has been identified as the etiologic agent of AIDS.
The HIV-1 protease is a member of the aspartic protease family of enzymes producing
essential structural and functional viral proteins by proteolytic processing of the gag- and gag-
pol viral gene products. Protease inhibitors have shown clinical efficacy for the treatment of
HIV-1 infection by reducing the plasma viral load in infected individuals. However, rapid
turnover of HIV-1 and the high frequency of mutations in the HIV genome eventually result in
the selection of mutant strains and in development of clinical resistance. For these reasons,
there is a need for development of new HIV-1 protease inhibitors. A solid phase parallel
synthesis approach was used for the generation of new unsymmetrical protease inhibitors
(Solid phase assisted synthesis of HIV-1 protease inhibitors. Expedient entry to unsymmetrical
substitution of a C2 symmetric template, K. Oscarsson et. al., Can. J. Chem., 78, (2000), 829-
837). A small library of eight individual compounds was synthesised on 3,4-dihydro-2H-2-
ylmethoxymethyl polystyrene solid phase resin. The compounds were tested for inhibition of
HIV-1 protease which identified several potent compounds. One of the most of which was (i)
which possessed an EC50 (50% inhibitory concentration) of 100 nM against HIV-1 protease.
This work may therefore prove useful in the further optimisation of antiviral activity for this
class of compounds.
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Polyketide natural products
The polyketides represent a rich reservoir of structurally complex, bioactive natural products,
many having therapeutic importance as antibiotics, anticancer agents, antifungals,
antiparasitics, immunosuppressants, and cardiovascular agents. In the archetypal case of the
erythromycin polyketide, the heptaketide precursor is assembled biosynthetically by the
polyketide synthase from a starter unit and six extender units, with the growing chain bound to
the acyl carrier protein. By mimicking this processive mechanism with a combinatorial library
synthetic approach, which uses a greater variety of chain extending units, a larger amount of
molecular diversity may be incorporated into final products belonging to this important
bioactive natural product class. (A combinatorial approach to polyketide-type libraries by
iterative asymmetric aldol reactions performed on solid support, I. Paterson et. al., Angew.
Chem. Int. Ed., 39, (2000), 3315-3319). A small library of five compounds was synthesised on
a polystyrene based solid support to demonstrate the potential of this method for generating
diverse polyketide product libraries. Boron-mediated aldol reactions of five chiral ketones was
used for efficient generation of novel polyketide-type sequences. This approach mimics the
processive mechanism of chain growth operating in the biosynthesis of polyketides and allows
much greater structural and stereochemical diversification through variation of the chain
extension reagents, as well as in the stereochemistry of the aldol and reduction steps. Thus,
this approach complements the combinatorial generation of new polyketide structures based
on the genetically engineered reconstruction of biosynthetic pathways, and may help to
produce novel polyketides having therapeutic importance.
